{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:49:24Z","timestamp":1791038964987,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1006\/exnr.1998.6976","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:46:56Z","timestamp":1032191216000},"page":"140-149","source":"Crossref","is-referenced-by-count":13,"title":["MPTP-Induced Pallidal Lesions in Rhesus Monkeys"],"prefix":"10.1006","volume":"155","author":[{"given":"Zhiming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calum","family":"Avison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don.M.","family":"Gash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/exnr.1998.6976_RF1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0024-3205(86)90431-5","article-title":"Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of I-methyl4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"39","author":"Bankiewicz","year":"1986","journal-title":"Life Sci."},{"key":"10.1006\/exnr.1998.6976_RF2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ana.410400305","article-title":"Treatment of advanced Parkinson's disease by Posterior GPi Pallidotomy: 1-Year results from a pilot study","volume":"40","author":"Baron","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6976_RF3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.410310202","article-title":"Dose impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illness","volume":"31","author":"Beal","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6976_RF4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/brain\/117.4.859","article-title":"The behavioral and motor consequences of focal lesions of the basal ganglia in man","volume":"117","author":"Bhatia","year":"1994","journal-title":"Brain"},{"key":"10.1006\/exnr.1998.6976_RF5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(84)90238-3","article-title":"[3H]Spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy","volume":"99","author":"Bokobza","year":"1984","journal-title":"Eur. J. Pharm."},{"key":"10.1006\/exnr.1998.6976_RF6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0006-8993(87)90602-0","article-title":"Behavioral and biochemical studies in monkeys made hemiparkinsonian by MPTP","volume":"419","author":"Brooks","year":"1987","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1998.6976_RF7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archneur.1996.00550070124020","article-title":"Pallidal lesions: Structural and functional magnetic resonance imaging","volume":"53","author":"Bucher","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1006\/exnr.1998.6976_RF8","series-title":"MPTP: A Neurotoxin Producing a Parkinsonian Syndrome","article-title":"The MPTP-treated monkey model of Parkinson's disease","author":"Burns","year":"1986"},{"key":"10.1006\/exnr.1998.6976_RF9","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/neu.480230915","article-title":"Excitotoxic cell death","volume":"23","author":"Choi","year":"1992","journal-title":"J. Neurobiol."},{"key":"10.1006\/exnr.1998.6976_RF10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"Delong","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1006\/exnr.1998.6976_RF11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0006-8993(90)90474-P","article-title":"MPTP-induced parkinsonism: Relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubral field of symptomatic and asymptomatic vervet monkeys","volume":"513","author":"Elsworth","year":"1990","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1998.6976_RF12","first-page":"1256","article-title":"Acute effect of the basal ganglia of intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to rhesus monkeys","volume":"21","author":"Forno","year":"1995","journal-title":"Soc. Neursci. Abstr."},{"key":"10.1006\/exnr.1998.6976_RF13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cne.903630302","article-title":"Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys","volume":"363","author":"Gash","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1006\/exnr.1998.6976_RF14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/380252a0","article-title":"Functional recovery in parkinsonian monkeys treated with GDNF","volume":"21","author":"Gash","year":"1996","journal-title":"Nature"},{"key":"10.1006\/exnr.1998.6976_RF15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ana.410350605","article-title":"Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease","volume":"35","author":"Greenamyre","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6976_RF16","first-page":"140","article-title":"Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: Possible neurochemical mechanisms","volume":"60","author":"Hornykiewicz","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1006\/exnr.1998.6976_RF17","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease","volume":"318","author":"Kish","year":"1998","journal-title":"New Eng. J. Med."},{"key":"10.1006\/exnr.1998.6976_RF18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3171\/jns.1992.76.1.0053","article-title":"Leksell's posteriorventral pallidotomy in the treatment of Parkinson's disease","volume":"76","author":"Laitinen","year":"1992","journal-title":"J Neurosurg."},{"key":"10.1006\/exnr.1998.6976_RF19","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1006\/exnr.1998.6976_RF20","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/brain\/112.3.699","article-title":"Obsessive-compulsive and other behavioral changes with bilateral basal ganglia lesions: A neuropsychological, magnetic resonance imaging and positron tomography study","volume":"112","author":"Laplane","year":"1989","journal-title":"Brain"},{"key":"10.1006\/exnr.1998.6976_RF21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0022-510X(65)90018-3","article-title":"The globus pallidus in post-encephalitic parkinsonism","volume":"2","author":"Martin","year":"1965","journal-title":"J. Neurol. Sci."},{"key":"10.1006\/exnr.1998.6976_RF22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0304-3940(86)90013-3","article-title":"Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: Relative contributions of the striatopallidial and striatonigral pathways as suggested by 2-deoxyglucose uptake","volume":"63","author":"Mitchell","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.1998.6976_RF23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ana.410420212","article-title":"Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys","volume":"42","author":"Miyoshi","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6976_RF24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1212\/WNL.46.2.492","article-title":"Manganese intoxication in the rhesus monkey: A clinical, imaging, pathologic, and biochemical study","volume":"46","author":"Olanow","year":"1996","journal-title":"Neurology"},{"key":"10.1006\/exnr.1998.6976_RF25","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0197-4580(95)02012-8","article-title":"Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys","volume":"16","author":"Ovadia","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1006\/exnr.1998.6976_RF26","first-page":"111","article-title":"The dopaminergic nigropallidial projection in primates: Distinct cellular origin and relative sparing in MPTP-treated monkeys","volume":"53","author":"Parent","year":"1990","journal-title":"Adv. Neurol."},{"key":"10.1006\/exnr.1998.6976_RF27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0166-2236(90)90105-J","article-title":"Extrinsic connections of the basal ganglia","volume":"13","author":"Parent","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1006\/exnr.1998.6976_RF28","series-title":"MPTP: A Neurotoxin Producing a Parkinsonian Syndrome","first-page":"141","article-title":"The neuropathology of MPTP-induced parkinsonism in man and experimental animals","author":"Parisi","year":"1986"},{"key":"10.1006\/exnr.1998.6976_RF29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0006-8993(91)90318-P","article-title":"Relative sparing of the dopaminergic innervation of the globus pallidus in monkeys made hemi-parkinsonian by intracarotid MPTP infusion","volume":"556","author":"Schneider","year":"1991","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1998.6976_RF30","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/WNL.50.6.1688","article-title":"Illicit drug associated ischemic stroke in the Baltimore\u2013Washington young stroke study","volume":"19","author":"Sloan","year":"1998","journal-title":"Neurology"},{"key":"10.1006\/exnr.1998.6976_RF31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0306-4522(93)90176-G","article-title":"Developing a stable bilateral model of parkinsonism in rhesus monkeys","volume":"52","author":"Smith","year":"1993","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.6976_RF32","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","article-title":"Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds","volume":"61","author":"Tipton","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.1998.6976_RF33","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0306-4522(95)00549-8","article-title":"Metabolic activity of the basal ganglia in parkinsonian syndromes in human and nonhuman primates: A cytochrome oxidase histochemistry study","volume":"71","author":"Vila","year":"1996","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.6976_RF34","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1523\/JNEUROSCI.17-02-00765.1997","article-title":"Consequences of Nigrostriatal denervation on the functioning of the basal ganglia in human and non-human primates: Anin situ","volume":"17","author":"Vila","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.1998.6976_RF35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1152\/jn.1994.72.2.521","article-title":"The primate subthalamic nucleus: Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism","volume":"72","author":"Wichman","year":"1994","journal-title":"J. Neurophysiol."},{"key":"10.1006\/exnr.1998.6976_RF36","first-page":"1396","article-title":"Dose Response to intraventricular GDNF administration in parkinsonian monkeys","volume":"282","author":"Zhang","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448869896976X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448869896976X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T13:01:18Z","timestamp":1576501278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448869896976X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["S001448869896976X"],"URL":"https:\/\/doi.org\/10.1006\/exnr.1998.6976","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}